Evidence map›Paper›PMID 25142870›Full record

Trial reportPharmacotherapy2014

Physician-pharmacist collaborative management of asthma in primary care.

Tyler H Gums, Barry L Carter, Gary Milavetz, Lucinda Buys, Kurt Rosenkrans, Liz Uribe, Christopher Coffey, Eric J MacLaughlin, Rodney B Young, Adrienne Z Ables and 2 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Pharmacotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Collaborative practice agreement in solid organ transplantation.International journal of clinical pharmacy · 2018
    Article
  17. Article
  18. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.The Journal of asthma : official journal of the Association for the Care of Asthma · 2017
    Article
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tyler H GumsDepartment of Pharmacy Practice & Science, University of Iowa College of Pharmacy, Iowa City, Iowa; Department of Family Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa.
Barry L Carter
Gary Milavetz
Lucinda Buys
Kurt Rosenkrans
Liz Uribe
Christopher Coffey
Eric J MacLaughlin
Rodney B Young
Adrienne Z Ables
Nima Patel-Shori
Angela Wisniewski

Funding

A collaborative model to improve BP control and minimize racial disparities-CCCR01HL091841 · NHLBI · UNIVERSITY OF IOWA · PI CARTER, BARRY L · 2009 to 2013
$4.7M
A collaborative model to improve BP control and minimize racial disparities--DCCR01HL091843 · NHLBI · UNIVERSITY OF IOWA · PI FOSTER, ERIC D. · 2009 to 2013
$3.6M
NHLBI NIH HHS R01 HL091841NHLBI NIH HHS R01HL091841NHLBI NIH HHS R01 HL091843NHLBI NIH HHS R01HL091843
6 · The paper itself

Abstract

objectiveTo determine if asthma control improves in patients who receive physician-pharmacist collaborative management (PPCM) during visits to primary care medical offices.

designProspective pre-post study of patients who received the intervention in primary care offices for 9 months. The primary outcome was the sum of asthma-related emergency department (ED) visits and hospitalizations at 9 months before, 9 months during, and 9 months after the intervention. Events were analyzed using linear mixed-effects regression. Secondary analysis was conducted for patients with uncontrolled asthma (Asthma Control Test [ACT] less than 20). Additional secondary outcomes included the ACT, the Asthma Quality of Life Questionnaire by Marks (AQLQ-M) scores, and medication changes.

interventionPharmacists provided patients with an asthma self-management plan and education and made pharmacotherapy recommendations to physicians when appropriate.

resultsOf 126 patients, the number of emergency department (ED) visits and/or hospitalizations decreased 30% during the intervention (p=0.052) and then returned to preenrollment levels after the intervention was discontinued (p=0.83). Secondary analysis of patients with uncontrolled asthma at baseline (ACT less than 20), showed 37 ED visits and hospitalizations before the intervention, 21 during the intervention, and 33 after the intervention was discontinued (p=0.019). ACT and AQLQ-M scores improved during the intervention (ACT mean absolute increase of 2.11, AQLQ-M mean absolute decrease of 4.86, p<0.0001) and sustained a stable effect after discontinuation of the intervention. Inhaled corticosteroid use increased during the intervention (p=0.024).

conclusionsThe PPCM care model reduced asthma-related ED visits and hospitalizations and improved asthma control and quality of life. However, the primary outcome was not statistically significant for all patients. There was a significant reduction in ED visits and hospitalizations during the intervention for patients with uncontrolled asthma at baseline. Our findings support the need for further studies to investigate asthma outcomes achievable with the PPCM model.

Indexed as

Cooperative BehaviorDisease ManagementPharmacistsPhysician's RoleAdultAsthmaFemaleFollow-Up StudiesHumansInterprofessional RelationsMaleMiddle AgedPrimary Health CareProspective StudiesYoung Adultasthmacollaborationpharmacistteam-based care

Identifiers

PMID25142870
PMCPMC4188693

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.